24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
specialties & services
Dr. Christopher Jones is a board certified radiation oncologist based in Sacramento, California. He graduated from the Rush Medical College and then did his internship at the MacNeal Memorial Hospital. Later, he pursued his residency in Radiation Oncology at the Massachusetts General Hospital. Dr. Jones has more than two decades of clinical experience and is currently affiliated with multiple hospitals including the Mercy General Hospital, Sutter Medical Center, and Marshall Medical Center. He has also contributed to several research publications.
Rush Medical College
Medical School
MacNeal Memorial Hospital
Internship
Massachusetts General Hospital
Residency
American Board of Radiology - Radiation Oncology
Marshall Medical Center
Languages: English/Spanish
(530) 622-1441
1100 Marshall Way
Placerville, California 95667 
Mercy General Hospital
Languages: English/Spanish
(916) 453-4545
4001 J St
Sacramento, California 95819
Mercy Hospital of Folsom
Languages: English/Spanish
(916) 983-7400
1650 Creekside Dr
Folsom, California 95630
Mercy San Juan Medical Center
Languages: English/Spanish
(916) 537-5000
6501 Coyle Ave
Carmichael, California 95608
Sutter Auburn Faith Hospital
Languages: English/Spanish
(530) 888-4500
11815 Education St
Auburn, California 95602
Sutter Davis Hospital
Languages: English/Spanish
(530) 756-6440
2000 Sutter Pl 2200
Davis, California 95616
Sutter Medical Center Sacramento
Languages: English/Spanish
(916) 887-1130
2825 Capitol Ave
Sacramento, California 95816
Sutter Roseville Medical Center
Languages: English/Spanish
(916) 781-1000
1 Medical Plaza Dr
Roseville, California 95661
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
Voog, J. C.,Paulus, R.,Shipley, W. U.,Smith, M. R.,McGowan, D. G.,Jones, C. U.,Bahary, J. P.,Zeitzer, K. L.,Souhami, L.,Leibenhaut, M. H.,Rotman, M.,Husain, S. M.,Gore...; Eur. Urol.. 2015 Sep 13.
See more >>
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
Koyfman, S. A.,Cooper, J. S.,Beitler, J. J.,Busse, P. M.,Jones, C. U.,McDonald, M. W.,Quon, H.,Ridge, J. A.,Saba, N. F.,Salama, J. K.,Siddiqui, F.,Smith, R. V.,Worden,...; Head Neck. 2016 Jan 23.
See more >>
Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer: Pilot Results From Radiation Therapy Oncology Group Protocol 0522.
Schwartz, D. L.,Harris, J.,Yao, M.,Rosenthal, D. I.,Opanowski, A.,Levering, A.,Ang, K. K.,Trotti, A. M.,Garden, A. S.,Jones, C. U.,Harari, P.,Foote, R.,Holland, J.,Zha...; Int. J. Radiat. Oncol. Biol. Phys.. 2015 Mar 11.
See more >>
Hospitals & Clinics
